Medtronic announces FDA approval of spinal cord stimulation platform
Click Here to Manage Email Alerts
Medtronic plc has announced FDA approval of the Vanta neurostimulator, an implantable spinal cord stimulation device with up to 11 years of recharge-free battery life, according to a press release.
The Vanta device uses a built-in accelerometer to provide patients with a personalized pain relief option. The device also allows for full-body MRI access with Medtronic’s SureScan technology, according to the release.
“We are committed to delivering innovative solutions that meets the needs of every patient,” Charlie Covert, vice president and general manager of pain therapies at Medtronic, said in the release. “For those who prefer or require a recharge-free device, I believe the Vanta neurostimulator offers the best hardware and features available today. We are pleased to offer this solution, which is now part of the strongest and broadest overall portfolio in this market,” Covert added.
Read more about
Click Here to Manage Email Alerts